eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension (2010)
- Authors:
- USP affiliated authors: CAVALLI, RICARDO DE CARVALHO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1038/tpj.2009.38
- Subjects: POLIMORFISMO; HIPERTENSÃO NA GRAVIDEZ; FARMACOGENÉTICA; PRÉ-ECLÂMPSIA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 10, n. 1, p. 40-45, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SANDRIM, V. C. et al. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension. The Pharmacogenomics Journal, v. 10, n. 1, p. 40-45, 2010Tradução . . Disponível em: https://doi.org/10.1038/tpj.2009.38. Acesso em: 28 dez. 2025. -
APA
Sandrim, V. C., Palei, A. C. T., Luizon, M. R., Izidoro-Toledo, T. C., Cavalli, R. de C., & Tanus-Santos, J. E. (2010). eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension. The Pharmacogenomics Journal, 10( 1), 40-45. doi:10.1038/tpj.2009.38 -
NLM
Sandrim VC, Palei ACT, Luizon MR, Izidoro-Toledo TC, Cavalli R de C, Tanus-Santos JE. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension [Internet]. The Pharmacogenomics Journal. 2010 ; 10( 1): 40-45.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1038/tpj.2009.38 -
Vancouver
Sandrim VC, Palei ACT, Luizon MR, Izidoro-Toledo TC, Cavalli R de C, Tanus-Santos JE. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestacional hypertension [Internet]. The Pharmacogenomics Journal. 2010 ; 10( 1): 40-45.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1038/tpj.2009.38 - Increased circulating cell-free hemoglobin levels reduce nitric biovailability in preeclampsia
- Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression
- Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia
- Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells
- Correlations among plasma Visfatin/NAMPT, nitrite and sFLT-1 levels, and gene interactions in the Visfatin/NAMPT pathway: role on pharmacogenetics of preeclampsia
- Elevation of circulating cell-free DNA levels inplasma of women with preeclampsia and gestational hypertension
- Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies
- Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms
- NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia
- Aldosterone synthase gene polymorphism is not associated with gestational hypertension or preeclampsia. [carta]
Informações sobre o DOI: 10.1038/tpj.2009.38 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
